Volume 20, Number 10—October 2014
Treatment of Giardiasis after Nonresponse to Nitroimidazole
|Patient age, y/sex||Travel history||No. failed nitroimidazole courses||Immunologic assessment||Alb||Nitaz||Quin||Paromo|
|35/M||Latin America||3||IgA deficiency||Failed||Failed||Cured||NA|
|23/M||Latin America||1||IgA deficiency||Cured‡||NA||NA||NA|
*Alb, albendazole; NA, not administered; ND, not done; nitaz, nitazoxanide; paromo, paromomycin; quin, quinacrine.
†Combination albendazole–tinidazole treatment.
‡Patient was clinically asymptomatic but did not provide a posttreatment fecal sample.
Page created: September 22, 2014
Page updated: September 22, 2014
Page reviewed: September 22, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.